The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and other publications ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Accord Healthcare’s Henlius-partnered Hetronifly ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

UK MHRA approves Accord Healthcare’s anti-PD-1 monoclonal antibody, serplulimab to treat aggressive form of SCLC: United Kingdom Monday, June 23, 2025, 09:00 Hrs [IST] The Medic ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Hetronifly (serplulimab) to treat adults ...

When small-cell lung cancer (SCLC) has spread to distant parts of the body, it’s classified as extensive-stage, which applies ...

Star running back Christian McCaffrey is primed for a comeback season with the San Francisco 49ers after an extended offseason, aiming to regain his peak performance and lead the team to success.

These results represent a significant step forward in SCLC treatment. Beyond specific data, Mulherin also addressed the overwhelming amount of information presented at ASCO, particularly for community ...

Adding lurbinectedin to atezolizumab for maintenance therapy in the first-line setting improved survival outcomes among patients with extensive-stage small cell lung cancer (ES-SCLC), according to ...

(RTTNews) - Jazz Pharmaceuticals plc (JAZZ) Tuesday said that the U.S. Food and Drug Administration (FDA) has granted priority review for the supplemental New Drug Application (sNDA) for Zepzelca ...

It received accelerated FDA approval in June 2020 for patients with metastatic SCLC with disease progression on or after platinum-based chemotherapy. 1 Atezolizumab is an immune checkpoint inhibitor ...